Etiguanfacine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEtiguanfacine
Drug Alias Nameguanfacine ethyl carbamateSSP-1871
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityHypertension

Other Information

ATC CodeN/A
Related LinksKEGG